1. Home
  2. QTTB vs POCI Comparison

QTTB vs POCI Comparison

Compare QTTB & POCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTTB
  • POCI
  • Stock Information
  • Founded
  • QTTB 2015
  • POCI 1982
  • Country
  • QTTB United States
  • POCI United States
  • Employees
  • QTTB N/A
  • POCI N/A
  • Industry
  • QTTB Biotechnology: Pharmaceutical Preparations
  • POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • QTTB Health Care
  • POCI Health Care
  • Exchange
  • QTTB Nasdaq
  • POCI Nasdaq
  • Market Cap
  • QTTB 40.0M
  • POCI 32.4M
  • IPO Year
  • QTTB N/A
  • POCI N/A
  • Fundamental
  • Price
  • QTTB $3.40
  • POCI $5.28
  • Analyst Decision
  • QTTB Buy
  • POCI
  • Analyst Count
  • QTTB 8
  • POCI 0
  • Target Price
  • QTTB $29.14
  • POCI N/A
  • AVG Volume (30 Days)
  • QTTB 215.6K
  • POCI 9.1K
  • Earning Date
  • QTTB 11-07-2024
  • POCI 02-12-2025
  • Dividend Yield
  • QTTB N/A
  • POCI N/A
  • EPS Growth
  • QTTB N/A
  • POCI N/A
  • EPS
  • QTTB N/A
  • POCI N/A
  • Revenue
  • QTTB N/A
  • POCI $18,980,148.00
  • Revenue This Year
  • QTTB N/A
  • POCI N/A
  • Revenue Next Year
  • QTTB N/A
  • POCI N/A
  • P/E Ratio
  • QTTB N/A
  • POCI N/A
  • Revenue Growth
  • QTTB N/A
  • POCI N/A
  • 52 Week Low
  • QTTB $2.90
  • POCI $3.47
  • 52 Week High
  • QTTB $53.79
  • POCI $6.90
  • Technical
  • Relative Strength Index (RSI)
  • QTTB 27.36
  • POCI 53.07
  • Support Level
  • QTTB $2.90
  • POCI $4.75
  • Resistance Level
  • QTTB $3.47
  • POCI $5.13
  • Average True Range (ATR)
  • QTTB 0.25
  • POCI 0.13
  • MACD
  • QTTB 0.63
  • POCI 0.01
  • Stochastic Oscillator
  • QTTB 45.59
  • POCI 77.27

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

Share on Social Networks: